"The U.S. Food and Drug Administration today approved Sivextro (tedizolid phosphate), a new antibacterial drug, to treat adults with skin infections.
Sivextro is approved to treat patients with acute bacterial skin and skin structure infecti"...
The patient should be told to:
- Avoid the use of occlusive dressings or wrappings unless otherwise directed by the physician.
- Keep Naftin® (naftifine) Gel, 1% away from the eyes, nose, mouth and other mucous membranes.
Last reviewed on RxList: 6/11/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Naftin Gel Information
Report Problems to the Food and Drug Administration
Find out what women really need.